Best practice tips for selecting a prepared media supplier
What does a good supplier look like? Andrew Ramage, Microbiology Product Specialist at Cherwell Laboratories, advises how to take the guesswork out of the search.
Any businesses requiring prepared media for microbiological testing activities, such as environmental monitoring, need to know two things: that all media is guaranteed to be of high quality and offer reliable results; and that confidence in the supplier is rooted in provable standards, certifications and validated processes.
Researching potential suppliers is, of course, essential, but where do you start with understanding what a good supplier looks like? There are many factors to consider - from their media manufacture processes, storage and transport to their depth of technical knowledge, and the kind of relationship you can expect to nurture.
Best practice tips for finding suppliers:
Once you have your own criteria mapped out, here are the key questions for your shortlisted potential suppliers:
Cherwell Laboratories, specialist suppliers of products for environmental monitoring and process validation, has published an eBook: The Pharmaceutical and Cleanroom Industry’s Pocket Guide to Prepared Culture Media. The guide, which is intended for anyone involved in using and/or buying microbiological media, aims to provide an understanding of the best practices and breadth of prepared culture media options for varying applications within the pharmaceutical and cleanroom industry.
The comprehensive guide equips the reader with all the information they need to consider in order to produce; purchase; store and use prepared media effectively. Focusing on the key topics covered in the guide will help readers to ensure their culture media is of a consistently high quality to deliver reliable results that they can be confident of, every time.
Topics within the guide include: an overview of the various applications of prepared media; best practice guidelines for handling and storing prepared media; the logistics of in-house prepared media manufacture; the argument for pre-prepared media versus in-house manufacturing and guidelines on how to choose a prepared media supplier.
Commenting on the eBook, Andrew Ramage says: “I hope this booklet will educate and inform the reader of the many considerations needed to manufacture high-quality microbiological growth media. A flexible and reliable manufacturer of prepared media will be able to guarantee the customer receives exactly the product they require, to a consistently high standard. Once the reader has finished reading this booklet they should also have a clearer understanding of the pros and cons of buying in prepared media versus manufacturing in-house.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance